Maykin Ho's Net Worth

$2.8 Million

Estimate Recalculated Nov 1, 2024 09:52AM EST

Who is Maykin Ho

Maykin Ho has an estimated net worth of $2.8 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., Neumora Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, FIBROGEN INC, and PAREXEL INTERNATIONAL CORP.

SEC CIK

Maykin Ho's CIK is 0001646395

Past Insider Trading and Trends

2018 was Maykin Ho's most active year for acquiring shares with 8 total transactions. Maykin Ho's most active month to acquire stocks was the month of May. 2023 was Maykin Ho's most active year for disposing of shares, totalling 3 transactions. Maykin Ho's most active month to dispose stocks was the month of April. 2024 saw Maykin Ho paying a total of $0.00 for 140,673 shares, this is the most they've acquired in one year. In 2023 Maykin Ho cashed out on 13,495 shares for a total of $148,591.05, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AGIOS PHARMACEUTICALS, INC.

Investor
Updated Jun 24, 2024
Form 4
13.89K
Jun 24, 2024
13.89K
Grant
Jun 20
Form 4
Jun 17, 2024
14.91K
Options
Jun 13
Form 4
Jun 23, 2023
11.52K
Options
Jun 21
Form 4
22.35K
Jun 15, 2023
22.35K
Grant
Jun 13
Form 4
34.28K
Jun 23, 2022
34.28K
Grant
Jun 21
Form 4
May 24, 2022
6.55K
Options
May 20
Form 4
Jun 02, 2021
4.96K
Options
May 28
Form 4
10.47K
May 24, 2021
10.47K
Grant
May 20
Form 4
298.41%
9.78K
Jun 01, 2020
13.06K
Options
May 28 - May 29
Form 4
771.21%
10.80K
May 31, 2019
12.20K
Options
May 29 - May 31
Form 4
7.10K
Jun 04, 2018
7.10K
Grant
May 31
Form 4
8.00K
Jun 15, 2017
8.00K
Grant
Jun 13
Form 4
37.65%
8.00K
Jun 23, 2016
29.25K
Grant
Jun 21
Form 4
21.25K
Jun 26, 2015
21.25K
Grant
Jun 23
Form 3
Jun 26, 2015
Showing 15 results

Neumora Therapeutics, Inc.

Investor
Updated Jun 14, 2024
Form 4
48.67K
Jun 14, 2024
48.67K
Grant
Jun 13
Form 4
27.80K
Sep 18, 2023
27.80K
Grant
Sep 14
Form 3
Sep 14, 2023
Showing 3 results

BIOMARIN PHARMACEUTICAL INC

Investor
Updated May 23, 2024
Form 4
28.37%
4.72K
May 23, 2024
21.36K
Grant
May 21
Form 4
33.65%
4.19K
May 24, 2023
16.64K
Grant
May 23
Form 4
66.67%
4.98K
May 26, 2022
12.45K
Grant
May 24
Form 4
217.87%
5.12K
May 27, 2021
7.47K
Grant
May 25
Form 4
2.35K
Feb 19, 2021
2.35K
Grant
Feb 17
Form 3
Feb 19, 2021
Showing 6 results

FIBROGEN INC

Investor
Updated Jun 06, 2024
Form 4
70.00K
Jun 06, 2024
70.00K
Grant
Jun 05
Form 4
39.19%
12.44K
$17.44
-$148.59K
Jun 09, 2023
44.17K
Grant
Jun 07 - Jun 08
Form 4
259.86%
41.46K
Jun 21, 2022
57.42K
Grant
Jun 16
Form 4
111.06%
12.50K
May 28, 2021
23.76K
Grant
May 26
Form 4
190.69%
12.50K
Jun 08, 2020
19.06K
Grant
Jun 04
Form 4
673.85%
12.50K
Jun 07, 2019
14.36K
Grant
Jun 05
Form 4/A
15.26K
Feb 07, 2019
15.26K
Grant
Dec 06
Form 4
15.26K
Dec 07, 2018
15.26K
Grant
Dec 05
Form 3
Dec 07, 2018
Showing 9 results

PAREXEL INTERNATIONAL CORP

Investor
Updated Oct 04, 2017
Form 4
-100.00%
-6.61K
Oct 04, 2017
Disposition
Sep 29
Form 4
38.07%
1.82K
Sep 11, 2017
6.61K
Grant
Sep 08
Form 4
97.89%
2.37K
Sep 16, 2016
4.79K
Grant
Sep 15
Form 4
2.42K
Sep 11, 2015
2.42K
Grant
Sep 10
Form 3
Sep 03, 2015
Showing 5 results